More News
HEALTHCARE | Staff Reporter, Singapore
view(s)

Hyphens Pharma Q3 net profit plummets by 53%

Despite the falling numbers, net profit for the first nine months of the year is still ahead of 2019 results.

Hyphens Pharma International Limited has noted that “challenges from COVID-19” have affected its profitability for the third quarter, withh a net profit loss of 53% for the three months to 30 September.

Revenue for Q3, however, rose from S$30.7m to S$31.4m, a 2.4% YoY increase.

The company still reported an increase of 5.5% YoY in the nine months ended 30 September despite grim results for Q3.

Hyphens Pharma’s proprietary brands reported the most contribution for 9M2020 earning S$13.6m from S$10.7m the previous year.
 

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

To get a media kit and information on advertising or sponsoring click here.